Medline (MDLN) Other Operating Expenses (2025 - 2026)

Medline's (MDLN) quarterly Other Operating Expenses came in at -$15.0 million in Q1 2026, down 87.5% year-on-year from -$120.0 million in Q1 2025, and down 87.5% on a QoQ basis from -$8.0 million in Q1 2025.

Medline (MDLN) Other Operating Expenses (2025 - 2026) Analysis & Trends

Medline (MDLN) has 2 years of Other Operating Expenses data on file, last reported at -$15.0 million in Q1 2026.

  • On a quarterly basis, Other Operating Expenses fell 87.5% year-over-year to -$15.0 million in Q1 2026; TTM through Mar 2026 was -$23.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$78.0 million, down 110.81% from the prior year.
  • Other Operating Expenses for Q1 2026 stood at -$15.0 million, down from -$8.0 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for MDLN reached as high as -$8.0 million in Q1 2025 and fell as low as -$15.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 -15.00 Mn
Mar 29, 2025 -8.00 Mn